Back to Search
SUPHAMAI BUNNAPRADIST, M.D.
M.D.
Nephrology Physician
NPI: 1821076639IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
A65633(CA)
Education
OTHER
Class of 1993
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.
PMID 36644348·Kidney Int Rep·2023
8-other
Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.
PMID 25196230·Am J Nephrol·2014
3-trial
Gastrointestinal-specific patient-reported outcome instruments differentiate between renal transplant patients with or without GI complications.
PMID 15848552·Transplant Proc·2005
4-observational
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.
PMID 14974944·Am J Transplant·2004
3-trial
Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection.
PMID 12492713·Am J Transplant·2003
8-other
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.
PMID 11522119·Drug Saf·2001
6-review
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
PMID 10868649·Transplantation·2000
4-observational
Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality.
PMID 18295064·Am J Kidney Dis·2008
8-other
Minimizing ciclosporin in renal transplant recipients on daclizumab, mycophenolate and steroids.
PMID 17579596·Nat Clin Pract Nephrol·2007
8-other
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure.
PMID 16861948·Transplantation·2006
8-other
Does plasmapheresis desensitize kidney transplant recipients more effectively than high-dose immunoglobulin?
PMID 16941039·Nat Clin Pract Nephrol·2006
8-other
Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
PMID 15848565·Transplant Proc·2005
8-other
Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants.
PMID 15848566·Transplant Proc·2005
8-other
Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
PMID 14611971·Transplant Proc·2003
4-observational
Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
PMID 12865780·Transplantation·2003
4-observational
Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States.
PMID 12660338·J Am Soc Nephrol·2003
4-observational
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database.
PMID 12506153·J Am Soc Nephrol·2003
8-other
Hepatitis C therapy with long term remission after renal transplantation.
PMID 12518964·Int J Artif Organs·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 UCLA MEDICAL PLZ STE 565C
LOS ANGELES, CA 90095 - Phone
- (310) 267-2555
Quick Facts
- NPI
- 1821076639
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile